Bd announces expanded 510(k) clearance for at-home system for ascites

Franklin lakes, n.j., june 23, 2021 /prnewswire/ -- bd (becton, dickinson and company) (nyse: bdx), a leading global medical technology company, today announced it has received 510(k) clearance from the u.s. food and drug administration (fda) for the peritx™ peritoneal catheter system for the drainage of symptomatic, recurrent non-malignant ascites.
BDX Ratings Summary
BDX Quant Ranking